149 related articles for article (PubMed ID: 2473128)
1. Functional alterations of herpes simplex virus-specific CD4+ multifunctional T cell clones following infection with human T lymphotropic virus type I.
Inatsuki A; Yasukawa M; Kobayashi Y
J Immunol; 1989 Aug; 143(4):1327-33. PubMed ID: 2473128
[TBL] [Abstract][Full Text] [Related]
2. Human T cell leukemia/lymphoma virus type I infection of a CD4+ proliferative/cytotoxic T cell clone progresses in at least two distinct phases based on changes in function and phenotype of the infected cells.
Yssel H; de Waal Malefyt R; Duc Dodon MD; Blanchard D; Gazzolo L; de Vries JE; Spits H
J Immunol; 1989 Apr; 142(7):2279-89. PubMed ID: 2466894
[TBL] [Abstract][Full Text] [Related]
3. Helper activity in antigen-specific antibody production mediated by CD4+ human cytotoxic T cell clones directed against herpes simplex virus.
Yasukawa M; Inatsuki A; Kobayashi Y
J Immunol; 1988 May; 140(10):3419-25. PubMed ID: 2452188
[TBL] [Abstract][Full Text] [Related]
4. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. II. Bifunctional clones with cytotoxic and virus-induced proliferative activities exhibit herpes simplex virus type 1 and 2 specific or type common reactivities.
Yasukawa M; Zarling JM
J Immunol; 1984 Nov; 133(5):2736-42. PubMed ID: 6207243
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the functional capabilities of CD3+CD4-CD8- and CD3+CD4+CD8+ human T cell clones.
Patel SS; Wacholtz MC; Duby AD; Thiele DL; Lipsky PE
J Immunol; 1989 Aug; 143(4):1108-17. PubMed ID: 2526180
[TBL] [Abstract][Full Text] [Related]
6. Functional modifications of alloreactive T cell clones infected with HTLV-I.
Suciu-Foca N; Rubinstein P; Rohowsky-Kochan C; Cai J; Popovic M; Gallo RC; King DW
J Immunol; 1986 Aug; 137(4):1115-9. PubMed ID: 3016087
[TBL] [Abstract][Full Text] [Related]
7. Functional heterogeneity among herpes simplex virus-specific human CD4+ T cells.
Yasukawa M; Inatsuki A; Horiuchi T; Kobayashi Y
J Immunol; 1991 Feb; 146(4):1341-7. PubMed ID: 1671404
[TBL] [Abstract][Full Text] [Related]
8. Evidence for involvement of the gamma, delta T cell antigen receptor in cytotoxicity mediated by human alloantigen-specific T cell clones.
Rivas A; Koide J; Cleary ML; Engleman EG
J Immunol; 1989 Mar; 142(6):1840-6. PubMed ID: 2466078
[TBL] [Abstract][Full Text] [Related]
9. Productive infection of CD4+ and CD8+ mature human T cell populations and clones by human herpesvirus 6. Transcriptional down-regulation of CD3.
Lusso P; Malnati M; De Maria A; Balotta C; DeRocco SE; Markham PD; Gallo RC
J Immunol; 1991 Jul; 147(2):685-91. PubMed ID: 1677024
[TBL] [Abstract][Full Text] [Related]
10. Differential in vitro activation of CD4+CD8- and CD8+CD4- herpes simplex virus-specific human cytotoxic T cells.
Yasukawa M; Inatsuki A; Kobayashi Y
J Immunol; 1989 Sep; 143(6):2051-7. PubMed ID: 2476493
[TBL] [Abstract][Full Text] [Related]
11. Human T cell leukemia/lymphoma virus-infected antigen-specific T cell clones: indiscriminant helper function and lymphokine production.
Volkman DJ; Popovic M; Gallo RC; Fauci AS
J Immunol; 1985 Jun; 134(6):4237-43. PubMed ID: 2580910
[TBL] [Abstract][Full Text] [Related]
12. Selective loss of T cell functions in different stages of HIV infection. Early loss of anti-CD3-induced T cell proliferation followed by decreased anti-CD3-induced cytotoxic T lymphocyte generation in AIDS-related complex and AIDS.
Gruters RA; Terpstra FG; De Jong R; Van Noesel CJ; Van Lier RA; Miedema F
Eur J Immunol; 1990 May; 20(5):1039-44. PubMed ID: 2162775
[TBL] [Abstract][Full Text] [Related]
13. Herpes simplex virus-specific human cytotoxic T-cell colonies expressing either gamma delta or alpha beta T-cell receptor: role of accessory molecules on HLA-unrestricted killing of virus-infected targets.
Maccario R; Comoli P; Percivalle E; Montagna D; Locatelli F; Gerna G
Immunology; 1995 May; 85(1):49-56. PubMed ID: 7635521
[TBL] [Abstract][Full Text] [Related]
14. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. IV. Recognition and activation by cloned glycoproteins gB and gD.
Zarling JM; Moran PA; Burke RL; Pachl C; Berman PW; Lasky LA
J Immunol; 1986 Jun; 136(12):4669-73. PubMed ID: 2423598
[TBL] [Abstract][Full Text] [Related]
15. Infection of human T lymphotropic virus-I-specific immune T cell clones by human T lymphotropic virus-I.
Mitsuya H; Jarrett RF; Cossman J; Cohen OJ; Kao CS; Guo HG; Reitz MS; Broder S
J Clin Invest; 1986 Nov; 78(5):1302-10. PubMed ID: 2877011
[TBL] [Abstract][Full Text] [Related]
16. Cellular interactions in the cytotoxic T lymphocyte response to herpes simplex virus antigens: differential antigen activation requirements for the helper T lymphocyte and cytotoxic T lymphocyte precursors.
Schmid DS; Rouse BT
J Immunol; 1983 Jul; 131(1):479-84. PubMed ID: 6223080
[TBL] [Abstract][Full Text] [Related]
17. Characterization of HTLV-I in vivo infected T cell clones. IL-2-independent growth of nontransformed T cells.
Höllsberg P; Wucherpfennig KW; Ausubel LJ; Calvo V; Bierer BE; Hafler DA
J Immunol; 1992 May; 148(10):3256-63. PubMed ID: 1374452
[TBL] [Abstract][Full Text] [Related]
18. Distinct proliferative T cell clonotypes are generated in response to a murine retrovirus-induced syngeneic T cell leukemia: viral gp70 antigen-specific MT4+ clones and Lyt-2+ cytolytic clones which recognize a tumor-specific cell surface antigen.
Matis LA; Ruscetti SK; Longo DL; Jacobson S; Brown EJ; Zinn S; Kruisbeek AM
J Immunol; 1985 Jul; 135(1):703-13. PubMed ID: 2582053
[TBL] [Abstract][Full Text] [Related]
19. Human T cell leukemia virus type I prevents cell surface expression of the T cell receptor through down-regulation of the CD3-gamma, -delta, -epsilon, and -zeta genes.
de Waal Malefyt R; Yssel H; Spits H; de Vries JE; Sancho J; Terhorst C; Alarcon B
J Immunol; 1990 Oct; 145(7):2297-303. PubMed ID: 2144550
[TBL] [Abstract][Full Text] [Related]
20. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. I. Lysis restricted by HLA class II MB and DR antigens.
Yasukawa M; Zarling JM
J Immunol; 1984 Jul; 133(1):422-7. PubMed ID: 6609990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
